Search results for "Arterial disease"

showing 10 items of 107 documents

Low-dose rivaroxaban plus aspirin in older patients with peripheral artery disease undergoing acute limb revascularization: insights from the VOYAGER…

2021

Abstract Aims In this secondary analysis of the VOYAGER trial, rivaroxaban 2.5 mg twice/day plus aspirin 100 mg/day was assessed in older adults. Advanced age is associated with elevated bleeding risk and unfavourable net benefit for dual antiplatelet therapy in chronic coronary artery disease. The risk–benefit of low-dose rivaroxaban in patients ≥75 years with peripheral artery disease (PAD) after lower extremity revascularization (LER) has not been described. Methods and results The primary endpoint was a composite of acute limb ischaemia, major amputation, myocardial infarction, ischaemic stroke, or cardiovascular death. The principal safety outcome was thrombolysis in myocardial infarct…

Acute limb ischaemiamedicine.medical_specialtyBrain IschemiaPeripheral Arterial DiseaseRivaroxabanInternal medicineClinical endpointHumansMedicineMyocardial infarctionAgedRivaroxabanAspirinbusiness.industryAbsolute risk reductionNumber needed to harmmedicine.diseaseStrokeCardiologyNumber needed to treatDrug Therapy CombinationCardiology and Cardiovascular MedicinebusinessPlatelet Aggregation InhibitorsTIMIFactor Xa Inhibitorsmedicine.drugEuropean Heart Journal
researchProduct

Prevalence of peripheral artery disease by abnormal ankle-brachial index in atrial fibrillation: implications for risk and therapy.

2013

AdultMaleRegistrieRiskMiddle AgedPeripheral Arterial Diseaseatrial fibrillation; cardiovascular disease; peripheral vascular disease; Adult; Aged; Atrial Fibrillation; Female; Humans; Internal Medicine; Italy; Male; Middle Aged; Peripheral Arterial Disease; Prevalence; Registries; Risk; Societies Medical; Ankle Brachial Index; Cardiology and Cardiovascular MedicineItalycardiovascular diseaseperipheral vascular diseaseMedicalAtrial FibrillationInternal MedicinePrevalenceHumansFemaleAnkle Brachial IndexRegistriesSocietiesCardiology and Cardiovascular MedicineSocieties MedicalAgedHuman
researchProduct

Erectile dysfunction is associated with low total serum testosterone levels and impaired flow-mediated vasodilation in intermediate risk men accordin…

2015

Background: The role erectile dysfunction (ED) coupled with low testosterone levels as early markers of atherosclerosis is not well understood. Objectives: To analyze the relationship between serum testosterone levels with both ED and brachial artery flow-mediated vasodilation (FMD), in a primary prevention sample of men. Methods: We enrolled 802 asymptomatic, intermediate CV risk patients, according to the Framingham Risk Score, aged 40e80 years, who underwent the ultrasound examination of FMD, the evaluation of ED and the assessment of total serum testosterone levels. Results: Testosterone levels correlated both with FMD (r ¼ 0.85; p < 0.0001) and IIEF-5 score (rs ¼ 0.65; p < 0.0001…

AdultMalemedicine.medical_specialtyBrachial ArteryFlow mediated vasodilationRisk AssessmentSeverity of Illness IndexAsymptomaticSettore MED/24 - UrologiaPeripheral Arterial DiseaseRisk Factorsmedicine.arteryInternal medicineDiabetes mellitusOdds RatioHumansMedicineTestosteroneErectile dysfunctionBrachial arteryAgedAged 80 and overSerum testosterone levelsChi-Square DistributionFramingham Risk Scorebusiness.industryEndothelial functionTestosterone (patch)Odds ratioMiddle Agedmedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareVasodilationLogistic ModelsEndocrinologyErectile dysfunctionRegional Blood FlowMultivariate AnalysisLinear ModelsCardiologymedicine.symptomCardiology and Cardiovascular MedicinebusinessBody mass indexBiomarkersAtherosclerosis
researchProduct

Artery occlusion independently predicts unfavorable outcome in cervical artery dissection

2020

ObjectiveTo assess the impact of dissected artery occlusion (DAO) on functional outcome and complications in patients with cervical artery dissection (CeAD).MethodsWe analyzed combined individual patient data from 3 multicenter cohorts of consecutive patients with CeAD (the Cervical Artery Dissection and Ischemic Stroke Patients [CADISP]–Plus consortium dataset). Patients with data on DAO and functional outcome were included. We compared patients with DAO to those without DAO. Primary outcome was favorable functional outcome (i.e., modified Rankin Scale [mRS] score 0–1) measured 3–6 months from baseline. Secondary outcomes included delayed cerebral ischemia, major hemorrhage, recurrent CeAD…

AdultMalemedicine.medical_specialtyCervical Arterymedicine.medical_treatment030204 cardiovascular system & hematologyRevascularizationArticle03 medical and health sciences0302 clinical medicineInterquartile rangeModified Rankin ScaleAneurysm DissectingInternal medicineHumansMedicineArtery occlusionStrokeAgedbusiness.industryOdds ratioRecovery of FunctionMiddle Agedmedicine.disease3. Good healthAortic DissectionCerebrovascular DisordersDissectionVINTAGECerebrovascular DisorderCardiologyFemale[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieCerebral Arterial DiseasesNeurology (clinical)businessCerebral Arterial Disease030217 neurology & neurosurgeryHuman
researchProduct

A multidisciplinary approach to assess recovery of consciousness in a patient with moyamoya disease

2019

Abstract Introduction Moyamoya disease (MMD) meaning “hazy puff of smoke” in Japanese is a rare chronic cerebrovascular syndrome characterized by progressive stenosis and occlusion of the internal carotid arteries (ICAs) anterior cerebral arteries (ACAs), and middle cerebral arteries (MCAs). Methods Our moyamoya patient with severely impaired cognitive and motor functions underwent a specific motor and neuropsychological rehabilitative treatments to assess the recovery of consciousness. Results Results obtained showed an improvement of clinical and neuropsychological examination. These findings highlighted the importance of an intensive rehabilitation techniques used in the care of disorder…

AdultMalemedicine.medical_specialtyConsciousnessmedicine.medical_treatmentCerebral arteriesNeuropsychological Tests050105 experimental psychologyrehabilitation03 medical and health sciencesBehavioral Neuroscience0302 clinical medicinePhysical medicine and rehabilitationOcclusionmedicineHumans0501 psychology and cognitive sciencesCarotid StenosisCognitive DysfunctionMoyamoya diseasedisorders of consciousnessneuropsychological evaluationPersistent vegetative stateOriginal ResearchRehabilitationbusiness.industry05 social sciencesNeuropsychologyNeurological RehabilitationCognitionRecovery of Functionmedicine.diseaseStenosisTreatment OutcomeItalyMotor SkillsCerebral Arterial DiseasesMoyamoya Diseasebusiness030217 neurology & neurosurgeryBrain and Behavior
researchProduct

One-year results from the DETOUR I trial of the PQ Bypass DETOUR System for percutaneous femoropopliteal bypass

2019

The objective of this study was to evaluate the 1-year safety and effectiveness outcomes associated with the PQ Bypass DETOUR System (PQ Bypass, Milpitas, Calif) for the percutaneous bypass of long-segment femoropopliteal occlusive disease.This prospective, single-arm, multicenter trial enrolled patients with long-segment femoropopliteal arterial disease. The DETOUR System percutaneously deploys modular stent grafts to bypass femoropopliteal lesions through a transvenous route. Eligible patients included those with TransAtlantic Inter-Society Consensus C and D lesions100 mm in length. The primary safety end point was the major adverse event (MAE) rate through 1 month, defined as the composi…

AdultMalemedicine.medical_specialtyPercutaneousAdolescentmedicine.medical_treatmentArterial Occlusive DiseasesKaplan-Meier Estimate030204 cardiovascular system & hematologyAmputation SurgicalLesionPeripheral Arterial DiseaseYoung Adult03 medical and health sciencesPostoperative Complications0302 clinical medicineMulticenter trialOcclusionmedicineHumansPopliteal ArteryProspective Studies030212 general & internal medicineAdverse effectVascular PatencyAgedAged 80 and overbusiness.industryEndovascular ProceduresStentIntermittent ClaudicationMiddle Agedmedicine.diseaseSurgeryFemoral ArteryStenosisTreatment OutcomeFemaleStentsSurgerymedicine.symptomCardiology and Cardiovascular MedicineClaudicationbusinessJournal of Vascular Surgery
researchProduct

Picotamide, a combined inhibitor of thromboxane A2 synthase and receptor, reduces 2-year mortality in diabetics with peripheral arterial disease: the…

2004

Aims Patients with diabetes are at excessive risk of mortality and cardiovascular morbidity. Previous studies suggest that aspirin may be less effective in diabetic patients. In this multi-centre, randomized, double blind trial picotamide, a dual inhibitor of thromboxane A2 synthase and receptor, was compared with aspirin for the prevention of mortality and major cardiovascular events in diabetics with peripheral arterial disease (PAD). Methods and results A total of 1209 adults aged 40–75 years with type 2 diabetes and PAD were randomized to receive picotamide (600 mg bid) or aspirin (320 mg od) for 24 months. The cumulative incidence of the 2 years overall mortality was significantly lowe…

AdultMalemedicine.medical_specialtyPhthalic AcidsType 2 diabetesDiabeteGastroenterologyThromboxane A2Double-Blind MethodRisk FactorsInternal medicineDiabetes mellitusPeripheral arterial diseasemedicineRisk of mortalityHumansPicotamideCumulative incidenceGeneral NursingAgedPeripheral Vascular DiseasesAspirinAspirinbiologybusiness.industryAntiplatelet therapyantiplatelet therapy; aspirin; diabetes; peripheral arterial disease; picotamide; thromboxane synthase inhibitorsMiddle Agedmedicine.diseaseSurvival AnalysisSurgeryThromboxane synthase inhibitors Indexed keywordsRelative riskbiology.proteinFemaleThromboxane-A synthasePicotamideCardiology and Cardiovascular MedicinebusinessDiabetic AngiopathiesPlatelet Aggregation InhibitorsFollow-Up Studiesmedicine.drugEuropean Heart Journal
researchProduct

Interdisciplinary treatment of diabetic foot wounds in the elderly : Low risk of amputations and mortality and good chance of being mobile with good …

2016

Aims: A major proportion of patients with diabetic foot syndrome are older than 65 years. Little is known about outcomes of these elderly patients. Methods: We analysed 245 treatment cases in an observational single-centre study for comorbidities and outcomes over a 6-month period. Results: In all, 122 patients had peripheral arterial disease which was significantly increasing with age ( n = 245, df = 1, χ2 = 23.06, p ⩽ 0.0001). Increasing age correlated positively with decreasing rate of revascularisations ( n = 122, df = 1, χ2 = 4.23, p = 0.039). In total, 23 (9.3%) patients died in the observation period. In-hospital mortality was 2.8%, percentage of major amputations 2.8%. In the invasi…

AdultMalemedicine.medical_specialtyTime FactorsArterial diseaseEndocrinology Diabetes and MetabolismObservation periodMedizin030209 endocrinology & metabolismComorbidity030204 cardiovascular system & hematologyAmputation Surgical03 medical and health sciences0302 clinical medicineQuality of lifeRisk FactorsGermanyDiabetes mellitusInternal medicineInternal MedicinemedicineHumansHospital MortalityMobility LimitationAgedRetrospective StudiesAged 80 and overPatient Care TeamWound HealingInterdisciplinary treatmentbusiness.industryEndovascular ProceduresAge FactorsRecovery of FunctionMiddle AgedLimb Salvagemedicine.diseaseDiabetic footDiabetic FootSurgeryTreatment OutcomeQuality of LifeFemaleObservational studyCardiology and Cardiovascular MedicinebusinessVascular Surgical Procedures
researchProduct

Peripheral arterial disease and its clinical significance in nonagenarians

2008

The purpose of this study was to characterize the prevalence and clinical features of peripheral arterial disease (PAD) among 90-year-old individuals and to assess its relationship to lower extremity functional status and survival over one year.A prospective, population- based study of all 90-year-old residents of Jyväskylä, Finland. Fifty-eight out of the 79 registered residents were examined for ankle-brachial index (ABI). Lower extremity functional status was assessed as self-reported difficulty in performing specific physical activities of daily living (PADL). In a subgroup of 36 individuals, lower extremity functioning was further assessed by measuring walking endurance and walking vel…

Agingmedicine.medical_specialtyActivities of daily livingArterial diseasePopulation030204 cardiovascular system & hematologyAsymptomatic03 medical and health sciences0302 clinical medicineRisk FactorsStatistical significanceInternal medicineActivities of Daily LivingHumansMedicineClinical significancecardiovascular diseases030212 general & internal medicineeducationAgedAged 80 and overPeripheral Vascular Diseaseseducation.field_of_studybusiness.industryPeripheralSurvival Ratebody regionsPhysical therapyFunctional statusGeriatrics and Gerontologymedicine.symptombusinesshuman activitiesLocomotionAging Clinical and Experimental Research
researchProduct

Microvascular brain damage with aging and hypertension

2011

Loss of cognitive function and hypertension are two common conditions in the elderly and both significantly contribute to loss of personal independency. Microvascular brain damage - the result of age-associated alteration in large arteries and the progressive mismatch of their cross-talk with small cerebral arteries - represents a potent risk factor for cognitive decline and for the onset of dementia in older individuals. The present review discusses the complexity of factors linking large artery to microvascular brain disease and to cognitive decline and the evidence for possible clinical markers useful for prevention of this phenomenon. The possibility of dementia prevention by cardiovasc…

Agingmedicine.medical_specialtyPathologyPhysiologyCerebral arteriesBrain damageRisk FactorsInternal medicineInternal MedicinemedicineHumansDementiaCognitive declineRisk factorAntihypertensive AgentsAgedAged 80 and overbusiness.industryCognitionMiddle Agedmedicine.diseaseClinical trialHypertensionMicrovesselsCardiologyArterial stiffnessIntracranial Arterial Diseasesmedicine.symptomCognition DisordersCardiology and Cardiovascular MedicinebusinessJournal of Hypertension
researchProduct